about
Echocardiography in the evaluation of athletesThe Changing Epidemiology of Infective Endocarditis in the Twenty-First Century.Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapyMidterm 'super-response' to cardiac resynchronization therapy by biventricular pacing with fusion: insights from electro-anatomical mappingInfective endocarditis in patients with an implanted transcatheter aortic valve: Clinical characteristics and outcome of a new entity.Transcatheter aortic valve implantation in patients with left main percutaneous coronary intervention.Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.[Prognostic value of cytokines and neurohormones in severe heart failure].Usefulness of transoesophageal echocardiography before circumferential pulmonary vein ablation in patients with atrial fibrillation: is it really mandatory?Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals.Prevention of sudden death in adolescent athletes: Incremental diagnostic value and cost-effectiveness of diagnostic tests.Usefulness of ventricular dyssynchrony measured using M-mode echocardiography to predict response to resynchronization therapy.Left Atrial Function Is Impaired in Some Patients With Stroke of Undetermined Etiology: Potential Implications for Evaluation and Therapy.Decreased likelihood of response to cardiac resynchronization in patients with severe heart failure.Differentiating hypertrophic cardiomyopathy from athlete's heart: An electrocardiographic and echocardiographic approach.Optimizing the programation of cardiac resynchronization therapy devices in patients with heart failure and left bundle branch block.Characterizing the spectrum of right ventricular remodelling in response to chronic training.Anodal capture in cardiac resynchronization therapy implications for device programming.Analysis of temporal delay in myocardial deformation throughout the cardiac cycle: utility for selecting candidates for cardiac resynchronization therapy.Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction.CMR-guided approach to localize and ablate gaps in repeat AF ablation procedure.Quantification of left ventricular asynchrony throughout the whole cardiac cycle with a computed algorithm: application for optimizing resynchronization therapy.Large protruding thrombus over left atrial appendage occlusion device successfully treated with apixaban.Biventricular pacing in hypertrophic obstructive cardiomyopathy: A pilot studyA rare association of pheochromocytoma and thoracic paraganglioma: utility of 2D contrast enhanced echocardiographyPre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablationIs there an anatomical substrate for idiopathic paroxysmal atrial fibrillation? A case-control echocardiographic study[Influence of cardiopathy etiology on responses to cardiac resynchronization therapy]Selective segmental ostial ablation and circumferential pulmonary veins ablation. Results of an individualized strategy to cure refractory atrial fibrillation[Severe tricuspidal insufficiency 20 years after an infectious endocarditis]Left atrial contractility is preserved after successful circumferential pulmonary vein ablation in patients with atrial fibrillationFate of left atrial function as determined by real-time three-dimensional echocardiography study after radiofrequency catheter ablation for the treatment of atrial fibrillationPredictors of arrhythmia recurrence in patients with lone atrial fibrillationAssessment of left ventricular dyssynchrony by real-time three-dimensional echocardiography[Radial artery spasm in transradial cardiac catheterization. Assessment of factors related to its occurrence, and of its consequences during follow-up]A giant left ventricular pseudoaneurysm in Behçet's diseaseRelation of response to cardiac resynchronization therapy to left ventricular reverse remodelingSix-minute walking test predicts long-term cardiac death in patients who received cardiac resynchronization therapyElectrocardiographic optimization of cardiac resynchronization devices: simple, but not so simple!Comparison of hemodynamic versus dyssynchrony assessment for interventricular delay optimization with echocardiography in cardiac resynchronization therapy
P50
Q26799926-79D33E9D-53FC-4A2C-9DAD-B7BF917B3152Q30234842-F82E1C16-AD3F-4CE9-A5C9-700F679E3F54Q33803826-E3EDE00E-5FB2-47E5-B063-AF9C81DAEC49Q37429345-CD0C6B4F-2EDA-44D4-AFBE-DB16196C96B1Q38308382-221B8A4C-2DB7-4760-928F-60500F3EEFC9Q39238499-1BFD7D5A-AD4C-4BBD-9FEB-5751CA7B902EQ43562281-20CF735A-E979-43E5-9E56-F4FB303C1BB1Q43997027-7A144F31-382B-4E42-A13A-F6D7A7446D9DQ44386531-3787A53A-0BBC-48E6-A58F-D6A7666FEC14Q47253446-C5AFB260-D87E-4086-B91E-0B4F3436D01DQ47339260-75D26D0E-55E8-4707-A230-DA1DAA433641Q48122595-B36BE40C-D747-4D68-BC6A-FD46DA99B16AQ48625094-E6561C7D-4880-415C-86A3-7FBDCB726F95Q48883827-796651EE-BFC0-4B78-BF08-D8099205622FQ50683255-D1BF5F29-43EE-4E06-8DF9-F36F46CAB445Q50916612-87008D4E-9641-49DA-BE8F-996B5EF82F82Q51064406-A513B3F2-3342-40C3-AA84-BFF0D22842F3Q51131741-183DE010-BB76-4C82-9B98-452030ECF607Q51680998-86F1F5CD-C942-4819-8DEB-E87C1CF29AEEQ51709186-33FC1309-17D7-4901-A748-1DDEEC2E19B2Q51724697-39F7F301-9A43-4A61-9600-9825D7F05309Q51817966-D1914B91-3FFC-4666-AA8D-ED66C01E7613Q53274627-1937D298-CC42-4707-8078-EFE829EB46B5Q58862379-22BA6AB5-9671-43B1-A681-98E8AF95DFBAQ79825973-72C2CF10-F9EE-468B-85BE-75137EF56B35Q80065140-AC8B0509-4F56-4435-911F-099990C43228Q80117829-824D1E0E-64FC-404E-BA11-858ABF8855A7Q80204339-333E9E88-ED06-4FDA-827A-D26095A1F5BAQ80548767-50E0C1E0-2E32-4216-9319-715A3D3A5D18Q80552466-D97334CC-3C25-4A18-B1B2-0D28114BD8AAQ80677857-941501C4-8CF5-4E75-9CFA-B3A1B0DAA0DDQ81150971-6813CF6F-D1D3-43F3-98BD-0D144983E2D9Q81589769-27FD5B16-B85D-4D90-BEBD-779BCFF1F487Q81750677-DFC01B9C-8FDF-4BB7-8AAC-BB4AE96CF9B4Q81755917-73A4B3A1-8D50-40D5-AA1E-D6481BEC9CD4Q81936940-CC4C16C1-E395-472C-9BF2-B58DB2043F1DQ82727548-90B1AC87-9FD5-4A90-8EAC-77A8CB25190AQ83172217-44273FCB-1577-4935-A86E-F42A172B4B35Q83444463-6F13E2E0-6904-4F70-9521-E4A33CC312E8Q83717590-91C5ACB6-39BC-49B0-8C9C-CC773C462F8A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
B Vidal
@ast
B Vidal
@en
B Vidal
@es
B Vidal
@nl
type
label
B Vidal
@ast
B Vidal
@en
B Vidal
@es
B Vidal
@nl
altLabel
Vidal B
@en
prefLabel
B Vidal
@ast
B Vidal
@en
B Vidal
@es
B Vidal
@nl
P106
P31
P496
0000-0003-4303-0851